Second Look—Advocacy

If you missed these Headline News Now items the first time around, AAOS Now gives you a second chance to review them. Headline News Now—the AAOS thrice-weekly, online update of news of interest to orthopaedic surgeons—brings you the latest on clinical, socioeconomic, and political issues, as well as important announcements from AAOS.

DePuy recalls two hip implants
DePuy Orthopaedics voluntarily recalled two hip replacement products due to higher-than-expected revision rates. According to data from the National Joint Registry of England and Wales, about 12 percent of patients receiving the company’s ASR Hip Resurfacing System and 13 percent of those receiving the ASR XL Acetabular System have undergone revision within 5 years. DePuy said that previous data had shown the devices performing similarly to other products in their class. The company states that it will pay for the cost of physician visits, tests, and other procedures associated with the recall. The resurfacing system was not offered for sale in the United States, although the acetabular system was available worldwide. Any products still on hospital shelves will be removed.

HHS approves EMR certifying organizations
Modern Healthcare
reports that the U.S. Department of Health and Human Services (HHS) has named Certification Commission for Health Information Technology (Chicago), and the Drummond Group (Austin, Texas) as qualified to test and certify EMR systems under the meaningful use criteria required by the American Recovery and Reinvestment Act of 2009. Under the Act, to be eligible for federal health information technology subsidies, healthcare providers must use certified EMRs in a meaningful manner.

This content is only available to members of the AAOS.

Please log in using the link at the top right corner of this page to access your exclusive AAOS member content.

Not a member? Become a member!